NatashaMcIntyre Clinician Scientist, London Health Sciences Centre, London, CanadaCanada

Dr McIntyre is a Clinician Scientist at London Health Sciences Centre in Ontario. She also holds Adjunct positions in the Department of Medicine, Schulich School of Medicine and Dentistry and the Arthur Labatt Family School of Nursing, Faculty of Health Sciences at The University of Western Ontario. She qualified as a registered nurse in 1991 in London, UK, where she specialized in Nephrology nursing and worked in the National Health Service (NHS) until moving to Canada in 2014. She held senior nursing leadership roles in the UK and has been involved in research and quality improvement for over 25 years in the NHS and Canada, especially in CKD management. She has also completed her MSc in Health Service Administration from Nottingham Business School where she built on her interest in improving healthcare for users. She has experience of employing key quality improvement methodologies in a healthcare setting on a local and wider strategic scale. In 2002 she collaborated with nephrology and primary care colleagues locally and nationally, to raise awareness and set up a strategy for early detection and management of people with mild to moderate Chronic Kidney Disease in primary care. She was a member of the National Clinical Guideline Development Group and Clinical Standards Group, for the Early Detection and Management of CKD, at the National Institute of Health and Clinical Excellence (NICE) (2007 to 2011). She completed her PhD at the University of Nottingham (‘Defining Chronic Kidney Disease in Primary Care’) funded by a peer-reviewed research fellowship from Kidney Research UK and the British Renal Society. Together with completing a post-doctoral fellowship in 2018, she has disseminated discoveries at national and international conferences as well as publication in a number of peer-reviewed journals, contributing to the evidence base for improving the quality of this previously unstudied group of people in the UK. Dr McIntyre was also a member of the UK national steering group (2007-2011) for the Dialysis Outcomes and Patient Patterns Study (DOPPS) that has informed a large evidence base for quality improvement for patients with Chronic and End Stage Kidney Disease, globally. Before moving to Canada, she was a member of the national steering group for an improvement initiative set up by the National Patient Safety Agency to reduce the incidence and harm caused by Acute Kidney Injury and driving forward its local implementation, employing innovative ways of working and commissioning to improve patient safety and quality of patient care. Since moving to Canada she has helped set up the Centre for Quality, Innovation and Safety (CQuInS) across London and was its Oerational Lead until 2022, where she was successful in gaining research funding and is currently researching the evolution of Virtual Care in the post pandemic era, in emerging models of care Between 2022-2024 she was a member of the KDIGO working group that developed the 2024 CKD Evaluation and Management Guidelines